BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22452439)

  • 1. Angiokeratoma: decision-making aid for the diagnosis of Fabry disease.
    Zampetti A; Orteu CH; Antuzzi D; Bongiorno MR; Manco S; Gnarra M; Morrone A; Cardinali G; Kovacs D; Aspite N; Linder D; Parini R; Feliciani C;
    Br J Dermatol; 2012 Apr; 166(4):712-20. PubMed ID: 22452439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset Fabry disease associated with angiokeratoma of Fordyce and multiple cherry angiomas.
    Hogarth V; Dhoat S; Mehta AB; Orteu CH
    Clin Exp Dermatol; 2011 Jul; 36(5):506-8. PubMed ID: 21457158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabry disease and the skin: data from FOS, the Fabry outcome survey.
    Orteu CH; Jansen T; Lidove O; Jaussaud R; Hughes DA; Pintos-Morell G; Ramaswami U; Parini R; Sunder-Plassman G; Beck M; Mehta AB;
    Br J Dermatol; 2007 Aug; 157(2):331-7. PubMed ID: 17573884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients.
    Navarro C; Teijeira S; Dominguez C; Fernandez JM; Rivas E; Fachal C; Barrera S; Rodriguez C; Iranzo P
    Acta Neuropathol; 2006 Feb; 111(2):178-85. PubMed ID: 16463201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anderson-Fabry disease: a multiorgan disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
    Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of patients with Fabry disease in Argentina].
    AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
    Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiokeratomas, not everything is Fabry disease.
    Cuestas D; Perafan A; Forero Y; Bonilla J; Velandia A; Gutierrez A; Motta A; Herrera H; Rolon M
    Int J Dermatol; 2019 Jun; 58(6):713-721. PubMed ID: 30656678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of multiple angiomas without any angiokeratomas in a female heterozygote with Fabry disease.
    Mirceva V; Hein R; Ring J; Möhrenschlager M
    Australas J Dermatol; 2010 Feb; 51(1):36-8. PubMed ID: 20148840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular pathology and clinical manifestations of Fabry disease].
    Rákóczi E; Görögh S; Grubits J; Erdos M; Garzuly F; Hahn K; Bencsik K; Vécsei L; Trinn C; Kristóf E; Mogyorósy G; Tóth B; Maródi L
    Orv Hetil; 2007 Jun; 148(23):1087-94. PubMed ID: 17545117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous complications of Anderson-Fabry disease.
    Giuseppe P; Daniele R; Rita BM
    Curr Pharm Des; 2013; 19(33):6031-6. PubMed ID: 23448454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabry disease: an atypical presentation.
    Choudhury S; Meehan S; Shin HT
    Pediatr Dermatol; 2005; 22(4):334-7. PubMed ID: 16060871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiokeratoma corporis diffusum (Fabry disease).
    Karen JK; Hale EK; Ma L
    Dermatol Online J; 2005 Dec; 11(4):8. PubMed ID: 16403380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiokeratoma corporis diffusum (Fabry disease). A lysosomal disease.
    Hashimoto K; Lieberman P; Lamkin N
    Arch Dermatol; 1976 Oct; 112(10):1416-23. PubMed ID: 183606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiokeratomas of Fabry successfully treated with intense pulsed light.
    Morais P; Santos AL; Baudrier T; Mota AV; Oliveira JP; Azevedo F
    J Cosmet Laser Ther; 2008 Dec; 10(4):218-22. PubMed ID: 18830871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabry disease: recognition and management of cutaneous manifestations.
    Möhrenschlager M; Braun-Falco M; Ring J; Abeck D
    Am J Clin Dermatol; 2003; 4(3):189-96. PubMed ID: 12627994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical spectrum of Anderson Fabry disease in a Romanian family.
    Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
    Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misdiagnosis of Fabry disease: importance of biochemical confirmation of clinical or pathological suspicion.
    Linthorst GE; De Rie MA; Tjiam KH; Aerts JM; Dingemans KP; Hollak CE
    Br J Dermatol; 2004 Mar; 150(3):575-7. PubMed ID: 15030345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis.
    Verrecchia E; Zampetti A; Antuzzi D; Ricci R; Ferri L; Morrone A; Feliciani C; Dagna L; Manna R
    Eur J Intern Med; 2016 Jul; 32():26-30. PubMed ID: 27083555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A family with Fabry disease diagnosed by a single angiokeratoma.
    Corry A; Feighery C; Alderdice D; Stewart F; Walsh M; Dolan OM
    Dermatol Online J; 2011 Apr; 17(4):5. PubMed ID: 21549080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor (VEGF-a) in Fabry disease: association with cutaneous and systemic manifestations with vascular involvement.
    Zampetti A; Gnarra M; Borsini W; Giurdanella F; Antuzzi D; Piras A; Smaldone C; Pieroni M; Cadeddu C; de Waure C; Feliciani C
    Cytokine; 2013 Mar; 61(3):933-9. PubMed ID: 23332617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.